RxNorm Semantic Concepts Index - 682
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "682".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 682 | AIB - Aminoisobutyric acid | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 682 | AIB - Aminoisobutyric acid | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 682 | AIB - Aminoisobutyric acid | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 68207 | Rhinovirus protease 2A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 6821 | Methanthelinium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 6821 | Methanthelinium | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 6821 | Methanthelinium | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 6821 | Methanthelinium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 682106 | Tyzeka | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 68213 | Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyl-transferase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 68213 | Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyl-transferase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 68217 | Aquacobalamin reductase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 68217 | Aquacobalamin reductase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 6822 | methapyrilene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 6823 | Methaqualone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 6823 | Methaqualone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 6823 | Methaqualone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 68244 | 3TC | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 68244 | 3TC | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 68244 | 3TC | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 68244 | 3TC | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 68244 | 3TC | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 68244 | 3TC | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 68244 | 3TC | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 6825 | metharbital | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 6825 | metharbital | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 6825 | metharbital | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 682524 | Zolinza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 6826 | Methazolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 6826 | Methazolamide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 6826 | Methazolamide | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 6826 | Methazolamide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 6826 | Methazolamide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 6826 | Methazolamide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 6827 | Methemalbumin | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 6827 | Methemalbumin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 6827 | Methemalbumin | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 6829 | Methemoglobin | British preferred term (PTGB) | NO | |
| Concept ID (RxCUI): 6829 | Methemoglobin | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 6829 | Methemoglobin | Full form of descriptor (FN) | NO |